A carregar...
Naftopidil for the treatment of urinary symptoms in patients with benign prostatic hyperplasia
Naftopidil, approved only in Japan, is an α1-adrenergic receptor antagonist (α1-blocker) used to treat lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH). Different from tamsulosin hydrochloride and silodosin, in that it has higher and extremely higher affinity resp...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2011
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3132093/ https://ncbi.nlm.nih.gov/pubmed/21753885 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S13883 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|